MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-HR-01-0002197
Epazote Pharmaceuticals Private Limited
Epazote Pharmaceuticals Private Limited - chemicals in Ambala, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹1.58 Lakh
Latest filing
Net loss · FY 2022
₹99,545
Net margin -63.1%
EBITDA · FY 2022
-₹99,545
EBITDA margin -63.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Epazote Pharmaceuticals Private Limited
Data last updated:
Epazote Pharmaceuticals Private Limited is a private limited company based in Ambala, Haryana, India. It operates in the basic chemicals except fertilizers and nitrogen compounds segment of the chemicals sector. It was incorporated on 01 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24110HR2020PTC088888. Its GSTIN is 06AAGCE0587R1Z1 (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vimal Chopra and Satyam Chopra.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Shop No. 7 S.A. Jain College Road Opp. Shamshan Ghat Shalimar Viharcolony, Ambala, Haryana, India – 134003.
As per the financials filed for FY 2022, the company reported a revenue of ₹1.58 Lakh. For the same year it recorded a net loss of ₹99,545 (net margin -63.1%) and EBITDA of -₹99,545 (EBITDA margin -63.1%).
Epazote Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-01-0002197).
Company details
CIN U24110HR2020PTC088888
Registration Number 088888
Incorporation Date 01 September 2020
ROC Haryana
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-HR-01-0002197
Recognitions & Rankings of Epazote Pharmaceuticals
Contact details
Epazote Pharmaceuticals Private Limited's registered office is in Ambala, Haryana. Its e-mail address is in the company report.
- Email
- Registered AddressShop No. 7 S.A. Jain College Road Opp. Shamshan Ghat Shalimar Viharcolony, Ambala, Haryana, India – 134003
- IndustryChemicals, Basic Chemicals Except Fertilizers And Nitrogen Compounds, Manufacturing, Basic Chemical
To see the full contact details of Epazote Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Epazote Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Epazote Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Epazote Pharmaceuticals Private Limited, buy the company report.
Financials of Epazote Pharmaceuticals Private Limited
FY 2022 filings availableEpazote Pharmaceuticals Private Limited reported revenue of ₹1.58 Lakh for FY 2022.
Revenue · FY 2022
₹1.58 Lakh
Net loss · FY 2022
₹99,545 margin -63.1%
EBITDA · FY 2022
-₹99,545 margin -63.1%
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹99,545 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹99,545 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -63.1% | |
| Net Profit Margin | -63.1% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Epazote Pharmaceuticals Private Limited, buy the company report.
Board of directors of Epazote Pharmaceuticals Private Limited
Epazote Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satyam Chopra | Additional Director | 03 May 2023 | 3 Years 6 Months | Current |
| Vimal Chopra Also directs: Glaxy-Gen Pharma Private Limited | Director | 01 Sep 2020 | 6 Years 2 Months | Current |
Peer comparison
Epazote Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Khusheal Pharmaceuticals Private Limited | ₹1.61 Lakh (FY 2025) | 246.0% | Thane, Maharashtra, India | |||
| Medleods Pharmaceuticals Private Limited | ₹1.6 Lakh (FY 2024) | -4.0% | Maharashtra, India | |||
| Paramba Pharmaceuticals Private Limited | ₹1.58 Lakh (FY 2024) | -8.0% | Bhardwaj Nagar, Mohan Eghu, Bihar, India | |||
| Epazote Pharmaceuticals Private Limitedthis company | ₹1.58 Lakh (FY 2022) | -₹99,545 | -63.1% | Ambala, Haryana, India |
To see the full peer comparison of Epazote Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Epazote Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Epazote Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Epazote Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAGCE0587R1Z1 | Haryana | Active | 10 Oct 2020 |
To see the full GST registrations and return filing status of Epazote Pharmaceuticals Private Limited, buy the company report.
Recent activity
Epazote Pharmaceuticals Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Ashwani Chawla ceased to be Director on 03 May 2023.
Ceased
Ashwani Chawla ceased to be Director.
Ceased
Gurcharan Lal ceased to be Director.
Appointed
Satyam Chopra was appointed as Additional Director.
AGM
Epazote Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Epazote Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Haryana.
Appointed
Vimal Chopra was appointed as Director.
Incorporation
01 Sep 2020
Epazote Pharmaceuticals Private Limited was registered on 01 Sep 2020 with Roc Haryana & aged 6 years 2 months as per MCA records.
Frequently asked questions
Epazote Pharmaceuticals is an active private limited company based in Ambala, Haryana, India. The company works in basic chemicals except fertilizers and nitrogen compounds, within the chemicals industry. It was incorporated on 01 September 2020 (6+ years old) and is registered under CIN U24110HR2020PTC088888.
Epazote Pharmaceuticals has 2 current directors:
- Satyam Chopra - Additional Director
- Vimal Chopra - Director
The latest financial statements of Epazote Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Epazote Pharmaceuticals is 06AAGCE0587R1Z1, registered in Haryana.
The CIN (Corporate Identification Number) of Epazote Pharmaceuticals is U24110HR2020PTC088888. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Epazote Pharmaceuticals was incorporated on 01 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Epazote Pharmaceuticals by revenue are Khusheal Pharmaceuticals Private Limited, Medleods Pharmaceuticals Private Limited, Paramba Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Ashwani Chawla ceased to be Director on 03 May 2023. Gurcharan Lal ceased to be Director on 03 May 2023. Satyam Chopra was appointed as Additional Director on 03 May 2023. Epazote Pharmaceuticals has 4 board changes on record in total.
Yes, Epazote Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-01-0002197).
The registered office of Epazote Pharmaceuticals is at Shop No. 7 S.A. Jain College Road Opp. Shamshan Ghat Shalimar Viharcolony, Ambala, Haryana, India – 134003.
Epazote Pharmaceuticals operates in the chemicals industry, in the basic chemicals except fertilizers and nitrogen compounds segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages